Assessment of the quality of evidence underlying international guidelines in liver disease

American Journal of Gastroenterology

Volumn 107, Issue 9, 2012, Pages 1276-1282

  Rowe, Ian A ^a,b   Parker, Richard ^a,b   Armstrong, Matthew J ^a,b   King, Andrew L ^a,b   Houlihan, Diarmaid D ^a,b   Mutimer, David ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; LIVER DISEASE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM;

EVIDENCE-BASED MEDICINE; HUMANS; LIVER DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84866131370     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.71     Document Type: Article

References (36)

1. Woolf SH. Practice guidelines: a new reality in medicine. I. Recent developments. Arch Intern Med 1990;150:1811-8.
2. Field MJ, Lohr KN (eds). Clinical Practice Guidelines: Directions for a New Agency. Institute of Medicine: Washington, DC, 1990.
3. Mehta RH, Roe MT, Chen AY et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006;166:2027-34.
4. Costantini O, Papp KK, Como J et al. Attitudes of faculty, housestaff, and medical students toward clinical practice guidelines. Acad Med 1999;74:1138-43.
5. Graham ID, Evans WK, Logan D et al. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario. Oncology 2000;59:283-90.
6. Yan AT, Yan RT, Tan M et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J 2007;154:1108-15.
7. Kappelman MD, Dorn SD, Peterson E et al. Quality of care for gastrointestinal conditions: a primer for gastroenterologists. Am J Gastroenterol 2011;106:1182-7.
8. Powers JH. Practice guidelines: belief, criticism, and probability. Arch Intern Med 2011;171:15-7.
9. Tricoci P, Allen JM, Kramer JM et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.
10. Lee DH, Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011;171:18-22.
11. Woolf SH, Sox HCJ. The Expert Panel on Preventive Services: continuing the work of the U. S. Preventive Services Task Force. Am J Prev Med 1991;7:326-30.
12. Gross PA, Barrett TL, Dellinger EP et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994;18:421.
13. American Heart Association. Methodology Manual http://my.americanheart. org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm-319826.pdf.
14. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
15. University of Oxford Centre for Evidence Based Medicine. Levels of Evidence http://www.cebm.net/index.aspx?o=1025 (2009). Accessed 30 September 2011.
16. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004;39:841-56.
17. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009;49:2087-107.
18. Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9.
19. Centers for Medicare and Medicaid Services. 2011 Physician Quality Reporting System (Physician Quality Reporting) Measures List https://www.cms.gov/PQRS/Downloads/2011-PhysQualRptg-MeasuresList-033111.pdf.
20. Ghany MG, Strader DB, Tomas DL et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74.
21. Craxi A. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011;55:245-64.
22. Kanwar M, Brar N, Khatib R et al. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007;131:1865-9.
23. Shekelle PG, Ortiz E, Rhodes S et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA 2001;286:1461-7.
24. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-2.
25. Browman GP Evidence-based clinical practice guideline development: principles, challenges, and accountability to evidence. J Surg Oncol 2010;101:1-2.
26. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-42.
27. Liaw YF, Leung N, Kao JH et al. Asian-Pacifc consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263-83.
28. European Association For The Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397-417.
29. Patch D, Burroughs A. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:1773-4.
30. Bass NM. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis. N Engl J Med 1999;341:443-4.
31. Detsky AS. Sources of bias for authors of clinical practice guidelines. CMAJ 2006;175:1033.
32. Shrier I, Boivin JF, Platt RW et al. The interpretation of systematic reviews with meta-analyses: an objective or subjective process? BMC Med Inform Decis Mak [online] 2008;8:19.
33. Falck-Ytter Y, Kunz R, Guyatt GH et al. How strong is the evidence? Am J Gastroenterol 2008;103:1334-8.
34. Brouwers MC, Somerfeld MR, Browman GP. A for efort: learning from the application of the GRADE approach to cancer guideline development. J Clin Oncol 2008;26:1025-6.
35. Corrao G, Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914-9.
36. Pessione F, Degos F, Marcellin P et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998;27:1717-22.